Cargando…

Intravesical Liposome and Antisense Treatment for Detrusor Overactivity and Interstitial Cystitis/Painful Bladder Syndrome

Purpose. The following review focuses on the recent advancements in intravesical drug delivery, which brings added benefit to the therapy of detrusor overactivity and interstitial cystitis/painful bladder syndrome (IC/PBS). Results. Intravesical route is a preferred route of administration for restr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tyagi, Pradeep, Kashyap, Mahendra P., Kawamorita, Naoki, Yoshizawa, Tsuyoshi, Chancellor, Michael, Yoshimura, Naoki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3914518/ https://www.ncbi.nlm.nih.gov/pubmed/24527221 http://dx.doi.org/10.1155/2014/601653

Ejemplares similares

Recent advances in imaging and understanding interstitial cystitis
por: Tyagi, Pradeep, et al.
Publicado: (2018)

Intravesical Resiniferatoxin for the Treatment of Storage Lower Urinary Tract Symptoms in Patients with Either Interstitial Cystitis or Detrusor Overactivity: A Meta-Analysis
por: Guo, Changcheng, et al.
Publicado: (2013)

Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis
por: Chen, Jing-Liang, et al.
Publicado: (2020)

The clinical application of intravesical botulinum toxin A injection in patients with overactive bladder and interstitial cystitis
por: Jiang, Yuan-Hong, et al.
Publicado: (2022)

Bladder Uptake of Liposomes after Intravesical Administration Occurs by Endocytosis
por: Rajaganapathy, Bharathi Raja, et al.
Publicado: (2015)

Interstitial cystitis intravesical therapy
por: Ha, Tanya, et al.
Publicado: (2017)

Characterization of the role of HCN channels in β3-adrenoceptor mediated rat bladder relaxation
por: Kashyap, Mahendra, et al.
Publicado: (2015)

Treatment of neurogenic detrusor overactivity and overactive bladder with Botox (onabotulinumtoxinA): Development, insights, and impact
por: Nitti, Victor, et al.
Publicado: (2023)

The Overlap of Interstitial Cystitis/Painful Bladder Syndrome and Overactive Bladder
por: Chung, Maurice K., et al.
Publicado: (2010)

Review of intravesical therapies for bladder pain syndrome/interstitial cystitis
por: Cvach, Kristina, et al.
Publicado: (2015)

Intravesical chondroitin sulphate for interstitial cystitis/painful bladder syndrome
por: Downey, A, et al.
Publicado: (2015)

Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
por: Al-Ghazo, Mohammed A., et al.
Publicado: (2011)

Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?
por: Kuo, Yuh-Chen, et al.
Publicado: (2016)

Dissimilar Effects of Tolterodine on Detrusor Overactivity in Awake Rats with Chemical Cystitis and Partial Bladder Outlet Obstruction
por: Jin, Long-Hu, et al.
Publicado: (2011)

Mechanisms Underlying Overactive Bladder and Interstitial Cystitis/Painful Bladder Syndrome
por: Grundy, Luke, et al.
Publicado: (2018)

Functional role of cannabinoid receptors in urinary bladder
por: Tyagi, Pradeep, et al.
Publicado: (2010)

Intravesical Injection of Abobotulinumtoxin-A in Patients with Bladder Pain Syndrome/Interstitial Cystitis
por: Rahnama’i, Mohammad-Sajjad, et al.
Publicado: (2023)

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
por: Tannenbaum, Stacey, et al.
Publicado: (2020)

Investigating Urine Biomarkers in Detrusor Underactivity and Detrusor Overactivity with Detrusor Underactivity Patients
por: Jiang, Yuan-Hong, et al.
Publicado: (2023)

Intravesical liposome drug delivery and IC/BPS
por: Janicki, Joseph J., et al.
Publicado: (2015)

Coexisting overactive–underactive bladder and detrusor overactivity–underactivity in pelvic organ prolapse
por: Frigerio, Matteo, et al.
Publicado: (2022)

AB121. Role of bladder hydrodistention and intravesical sodium hyaluronate in the treatment of interstitial cystitis
por: Yang, Jin-Yi, et al.
Publicado: (2016)

Impact of intravesical hyaluronic acid treatment on bladder inflammation in interstitial cystitis rat model
por: Sahiner, Ilker Fatih, et al.
Publicado: (2018)

Development and Changes with Age of Detrusor Overactivity in Spontaneous Hypertensive Rats as Observed by Simultaneous Registrations of Intravesical and Intraabdominal Pressures
por: Jin, Long-Hu, et al.
Publicado: (2011)

Improves symptoms and urinary biomarkers in refractory interstitial cystitis/bladder pain syndrome patients randomized to extracorporeal shock wave therapy versus placebo
por: Shen, Yuan-Chi, et al.
Publicado: (2021)

Current Understanding and Future Perspectives of Interstitial Cystitis/Bladder Pain Syndrome
por: Ueda, Tomohiro, et al.
Publicado: (2021)

A rat long‐lasting cystitis model induced by intravesical injection of hydrogen peroxide
por: Dogishi, Koji, et al.
Publicado: (2017)

Development of an interstitial cystitis risk score for bladder permeability
por: Lamb, Laura E., et al.
Publicado: (2017)

Interstitial Cystitis Can Be Improved With Intravesical Instillation of Platelet-Rich Plasma
por: Hardy, Timothy J
Publicado: (2022)

Efficacy of intravesical cocktail therapy with or without dimethyl sulphoxide in interstitial cystitis
por: Sogutdelen, Emrullah, et al.
Publicado: (2022)

Overactive bladder with urodynamic study-induced bladder pain: An overactive bladder subtype with symptoms similar to those of interstitial cystitis/painful bladder syndrome
por: Mu, Hsueh-Yu, et al.
Publicado: (2023)

Characterization of upper lamina propria interstitial cells in bladders from patients with neurogenic detrusor overactivity and bladder pain syndrome
por: Gevaert, Thomas, et al.
Publicado: (2011)

In what type of interstitial cystitis/bladder pain syndrome is DMSO intravesical instillation therapy effective?
por: Tomoe, Hikaru
Publicado: (2015)

Botulinum Toxin in Neurogenic Detrusor Overactivity
por: D'Ancona, Carlos Arturo Levi, et al.
Publicado: (2012)

Increased detrusor collagen is associated with detrusor overactivity and decreased bladder compliance in men with benign prostatic obstruction
por: Bellucci, Carlos H.S., et al.
Publicado: (2017)

Urinary ATP May Be a Dynamic Biomarker of Detrusor Overactivity in Women with Overactive Bladder Syndrome
por: Silva-Ramos, Miguel, et al.
Publicado: (2013)

Differences in the Urinary Microbiome of Patients with Overactive Bladder Syndrome with and without Detrusor Overactivity on Urodynamic Measurements
por: Javan Balegh Marand, Aida, et al.
Publicado: (2023)

Effectiveness of intravesical ozone in interstitial cystitis by the O'Leary–Sant symptom index
por: Pires, Maria Verônica, et al.
Publicado: (2022)

Recurrence after postoperative intravesical instillation therapy in Hunner type interstitial cystitis
por: Ko, Kwang Jin, et al.
Publicado: (2023)

Urodynamic Effects of Propiverine on Detrusor Overactivity and Abdominal Straining during Voiding in Awake Rats with Intravesical Prostaglandin E(2) Instillation
por: Oh, Jun Hyung, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_ih4hnt58mql39n4cq8trpq5d44